Brooks O'Neil
Stock Analyst at Lake Street
(0.91)
# 3,808
Out of 4,918 analysts
37
Total ratings
30.56%
Success rate
-17.53%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Buy | $12 → $18 | $9.94 | +81.09% | 2 | Jul 10, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $6.52 | +206.75% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $36.00 | +19.44% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $81.09 | +35.65% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $16.40 | +82.93% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $34.46 | +106.04% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $2.70 | +270.37% | 3 | Jan 13, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $20 → $14 | $5.16 | +171.32% | 6 | Jan 8, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $12.52 | +107.67% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $31.23 | +76.11% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $13.77 | +30.72% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.51 | +10.86% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $75 | $15.40 | +387.01% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $7.16 | +67.71% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $18.13 | +43.41% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $5.32 | +746.15% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.72 | +1,438.46% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $36.24 | +251.82% | 1 | Sep 15, 2020 |
LifeMD
Jul 10, 2025
Maintains: Buy
Price Target: $12 → $18
Current: $9.94
Upside: +81.09%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $6.52
Upside: +206.75%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $36.00
Upside: +19.44%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $81.09
Upside: +35.65%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $16.40
Upside: +82.93%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $34.46
Upside: +106.04%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $2.70
Upside: +270.37%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.16
Upside: +171.32%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $12.52
Upside: +107.67%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $31.23
Upside: +76.11%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $13.77
Upside: +30.72%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.51
Upside: +10.86%
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $15.40
Upside: +387.01%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $7.16
Upside: +67.71%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $18.13
Upside: +43.41%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $5.32
Upside: +746.15%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.72
Upside: +1,438.46%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $36.24
Upside: +251.82%